Syensqo and Emulseo collaborate to advance microfluidic technology in healthcare sector
Exploring new opportunities within the fast-growing market of microfluidics
Exploring new opportunities within the fast-growing market of microfluidics
Afrezza, developed by MannKind Corporation in the USA, offers a needle-free, rapid-acting insulin option for diabetes management
The product will be marketed by Dr. Reddy's
Jagsonpal Pharmaceuticals has received full consideration of Rs. 41 crore towards the sale of the facility and will now be proceeding with registration formalities
Q2 FY25 Total Income was at Rs. 85.4 crore
Combined capabilities to drive novel healthcare applications presented at MEDICA 2024
Neuland Laboratories has reported total income of Rs. 315.17 crores during the period ended September 30, 2024
Dr. Reddy's Laboratories has reported total income of Rs. 8,016.2 crores during the period ended September 30, 2024
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies
Subscribe To Our Newsletter & Stay Updated